OP 11
Efficacy and safety of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment: results of the phase 2 dare study
E. Terpos1,*, A. Symeonidis2, S. Delimpasi3, E. Zamagni4, E. Katodritou5, E. Rivolti6, M. Kyrtsonis7, D. Fotiou1, N. Kanellias1, M. Migkou1, M. Roussou1, M. Gavriatopoulou1, E. Hatjiharissi8, M. Cavo4, M. Dimopoulos1
1 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
2 Hematology Division, Department of Internal Medicine, University of Patras Medical School, Patras, Greece
3 Department of Hematology and Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece
4 Seragnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
5 Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece
6 Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy
7 First Department of Propedeutic Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
8 First Department of Internal Medicine, Aristotle University of Thessaloniki, School of Medicine, AHEPA University Hospital, Thessaloniki, Greece
Lido
2830
Vezesque se leu este artigo
1121
Total PDF
1709
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 48 | 10 | 58 |
| 2025 5 | 77 | 13 | 90 |
| 2025 4 | 77 | 13 | 90 |
| 2025 3 | 75 | 13 | 88 |
| 2025 2 | 51 | 22 | 73 |
| 2025 1 | 44 | 17 | 61 |
| 2024 12 | 35 | 11 | 46 |
| 2024 11 | 51 | 17 | 68 |
| 2024 10 | 37 | 20 | 57 |
| 2024 9 | 41 | 21 | 62 |
| 2024 8 | 30 | 19 | 49 |
| 2024 7 | 38 | 14 | 52 |
| 2024 6 | 37 | 29 | 66 |
| 2024 5 | 44 | 23 | 67 |
| 2024 4 | 39 | 14 | 53 |
| 2024 3 | 38 | 13 | 51 |
| 2024 2 | 33 | 25 | 58 |
| 2024 1 | 32 | 26 | 58 |
| 2023 12 | 34 | 23 | 57 |
| 2023 11 | 65 | 46 | 111 |
| 2023 10 | 30 | 27 | 57 |
| 2023 9 | 33 | 31 | 64 |
| 2023 8 | 32 | 17 | 49 |
| 2023 7 | 33 | 8 | 41 |
| 2023 6 | 37 | 28 | 65 |
| 2023 5 | 40 | 21 | 61 |
| 2023 4 | 22 | 2 | 24 |
| 2023 3 | 16 | 14 | 30 |
| 2023 2 | 28 | 11 | 39 |
| 2023 1 | 17 | 7 | 24 |
| 2022 12 | 23 | 14 | 37 |
| 2022 11 | 26 | 20 | 46 |
| 2022 10 | 28 | 17 | 45 |
| 2022 9 | 23 | 17 | 40 |
| 2022 8 | 22 | 24 | 46 |
| 2022 7 | 22 | 30 | 52 |
| 2022 6 | 16 | 20 | 36 |
| 2022 5 | 18 | 22 | 40 |
| 2022 4 | 22 | 33 | 55 |
| 2022 3 | 23 | 18 | 41 |
| 2022 2 | 19 | 27 | 46 |
| 2021 1 | 9 | 11 | 20 |
| 2021 12 | 17 | 21 | 38 |
| 2021 11 | 24 | 24 | 48 |
| 2021 10 | 12 | 29 | 41 |
| 2021 9 | 23 | 32 | 55 |
| 2021 8 | 23 | 23 | 46 |
| 2021 7 | 14 | 13 | 27 |
| 2021 6 | 14 | 22 | 36 |
| 2021 5 | 23 | 45 | 68 |
| 2021 4 | 24 | 36 | 60 |
| 2021 3 | 22 | 21 | 43 |
| 2021 2 | 18 | 9 | 27 |
| 2020 1 | 15 | 15 | 30 |
| 2020 12 | 6 | 12 | 18 |
| 2020 11 | 9 | 11 | 20 |
Mostrar tudo
